Soleno Therapeutics Insider Sold Shares Worth $3,044,343, According to a Recent SEC Filing

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Soleno Therapeutics Insider Sold Shares Worth $3,044,343, According to a Recent SEC Filing

, MT Newswires - 3:22 AM ET 4/1/2025 default

03:22 AM EDT, 04/01/2025 (MT Newswires) -- Meredith Manning, Chief Commercial Officer, on March 27, 2025, sold 45,249 shares in Soleno Therapeutics ( SLNO ) for $3,044,343. Following the Form 4 filing with the SEC, Manning has control over a total of 45,351 common shares of the company, with 45,351 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1484565/000141588925009296/xslF345X05/form4-03312025_110359.xml

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.